Nina Hallowell, S Wright, D Stirling, C Gourley, O Young, M Porteous. Fam Cancer 2019
Times Cited: 22
Times Cited: 22
Times Cited
Times Co-cited
Similarity
Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients.
Angela George, Daniel Riddell, Sheila Seal, Sabrina Talukdar, Shazia Mahamdallie, Elise Ruark, Victoria Cloke, Ingrid Slade, Zoe Kemp, Martin Gore,[...]. Sci Rep 2016
Angela George, Daniel Riddell, Sheila Seal, Sabrina Talukdar, Shazia Mahamdallie, Elise Ruark, Victoria Cloke, Ingrid Slade, Zoe Kemp, Martin Gore,[...]. Sci Rep 2016
50
Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.
Zoe Kemp, Alice Turnbull, Shawn Yost, Sheila Seal, Shazia Mahamdallie, Emma Poyastro-Pearson, Margaret Warren-Perry, Anthony Eccleston, Min-Min Tan, Soo Hwang Teo,[...]. JAMA Netw Open 2019
Zoe Kemp, Alice Turnbull, Shawn Yost, Sheila Seal, Shazia Mahamdallie, Emma Poyastro-Pearson, Margaret Warren-Perry, Anthony Eccleston, Min-Min Tan, Soo Hwang Teo,[...]. JAMA Netw Open 2019
27
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
22
Mainstreamed genetic testing for women with ovarian cancer: first-year experience.
Belinda Rahman, Anne Lanceley, Rebecca S Kristeleit, Jonathan A Ledermann, Michelle Lockley, Mary McCormack, Tim Mould, Lucy Side. J Med Genet 2019
Belinda Rahman, Anne Lanceley, Rebecca S Kristeleit, Jonathan A Ledermann, Michelle Lockley, Mary McCormack, Tim Mould, Lucy Side. J Med Genet 2019
22
Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.
Nicoletta Colombo, Gloria Huang, Giovanni Scambia, Eva Chalas, Sandro Pignata, James Fiorica, Linda Van Le, Sharad Ghamande, Santiago González-Santiago, Isabel Bover,[...]. J Clin Oncol 2018
Nicoletta Colombo, Gloria Huang, Giovanni Scambia, Eva Chalas, Sandro Pignata, James Fiorica, Linda Van Le, Sharad Ghamande, Santiago González-Santiago, Isabel Bover,[...]. J Clin Oncol 2018
22
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
Mark Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine Tung, Anne Armstrong,[...]. N Engl J Med 2017
Mark Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine Tung, Anne Armstrong,[...]. N Engl J Med 2017
18
The integration of BRCA testing into oncology clinics.
Natalie Percival, Angela George, Jennifer Gyertson, Monica Hamill, Andreia Fernandes, Emily Davies, Nazneen Rahman, Susana Banerjee. Br J Nurs 2016
Natalie Percival, Angela George, Jennifer Gyertson, Monica Hamill, Andreia Fernandes, Emily Davies, Nazneen Rahman, Susana Banerjee. Br J Nurs 2016
18
Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
Maira Kentwell, Eryn Dow, Yoland Antill, C David Wrede, Orla McNally, Emily Higgs, Anne Hamilton, Sumitra Ananda, Geoffrey J Lindeman, Clare L Scott. Gynecol Oncol 2017
Maira Kentwell, Eryn Dow, Yoland Antill, C David Wrede, Orla McNally, Emily Higgs, Anne Hamilton, Sumitra Ananda, Geoffrey J Lindeman, Clare L Scott. Gynecol Oncol 2017
18
Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary Cancer.
Jeanna M McCuaig, Susan Randall Armel, Melanie Care, Alexandra Volenik, Raymond H Kim, Kelly A Metcalfe. Cancers (Basel) 2018
Jeanna M McCuaig, Susan Randall Armel, Melanie Care, Alexandra Volenik, Raymond H Kim, Kelly A Metcalfe. Cancers (Basel) 2018
13
American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
13
Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
Terri Febbraro, Katina Robison, Jennifer Scalia Wilbur, Jessica Laprise, Amy Bregar, Vrishali Lopes, Robert Legare, Ashley Stuckey. Gynecol Oncol 2015
Terri Febbraro, Katina Robison, Jennifer Scalia Wilbur, Jessica Laprise, Amy Bregar, Vrishali Lopes, Robert Legare, Ashley Stuckey. Gynecol Oncol 2015
13
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
13
Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics.
Liza-Marie Johnson, Jessica M Valdez, Emily A Quinn, April D Sykes, Rose B McGee, Regina Nuccio, Stacy J Hines-Dowell, Justin N Baker, Chimene Kesserwan, Kim E Nichols,[...]. Cancer 2017
Liza-Marie Johnson, Jessica M Valdez, Emily A Quinn, April D Sykes, Rose B McGee, Regina Nuccio, Stacy J Hines-Dowell, Justin N Baker, Chimene Kesserwan, Kim E Nichols,[...]. Cancer 2017
13
Are physicians prepared for whole genome sequencing? a qualitative analysis.
K D Christensen, J L Vassy, L Jamal, L S Lehmann, M J Slashinski, D L Perry, J O Robinson, J Blumenthal-Barby, L Z Feuerman, M F Murray,[...]. Clin Genet 2016
K D Christensen, J L Vassy, L Jamal, L S Lehmann, M J Slashinski, D L Perry, J O Robinson, J Blumenthal-Barby, L Z Feuerman, M F Murray,[...]. Clin Genet 2016
13
Building towards precision medicine: empowering medical professionals for the next revolution.
Scott McGrath, Dario Ghersi. BMC Med Genomics 2016
Scott McGrath, Dario Ghersi. BMC Med Genomics 2016
13
Non-genetic health professionals' attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancer.
Kirsten F L Douma, Ellen M A Smets, Dawn C Allain. Fam Cancer 2016
Kirsten F L Douma, Ellen M A Smets, Dawn C Allain. Fam Cancer 2016
13
Communication and information needs of women diagnosed with ovarian cancer regarding treatment-focused genetic testing.
Margaret Gleeson, Bettina Meiser, Kristine Barlow-Stewart, Alison H Trainer, Kathy Tucker, Kaaren J Watts, Michael Friedlander, Nadine Kasparian. Oncol Nurs Forum 2013
Margaret Gleeson, Bettina Meiser, Kristine Barlow-Stewart, Alison H Trainer, Kathy Tucker, Kaaren J Watts, Michael Friedlander, Nadine Kasparian. Oncol Nurs Forum 2013
13
Alternate Service Delivery Models in Cancer Genetic Counseling: A Mini-Review.
Adam Hudson Buchanan, Alanna Kulchak Rahm, Janet L Williams. Front Oncol 2016
Adam Hudson Buchanan, Alanna Kulchak Rahm, Janet L Williams. Front Oncol 2016
13
Patients' Views of Treatment-Focused Genetic Testing (TFGT): Some Lessons for the Mainstreaming of BRCA1 and BRCA2 Testing.
Sarah Wright, Mary Porteous, Diane Stirling, Julia Lawton, Oliver Young, Charlie Gourley, Nina Hallowell. J Genet Couns 2018
Sarah Wright, Mary Porteous, Diane Stirling, Julia Lawton, Oliver Young, Charlie Gourley, Nina Hallowell. J Genet Couns 2018
20
Evaluation of telephone genetic counselling to facilitate germline BRCA1/2 testing in women with high-grade serous ovarian cancer.
Erin Tutty, Lara Petelin, Joanne McKinley, Mary-Anne Young, Bettina Meiser, Victoria M Rasmussen, Rowan Forbes Shepherd, Paul A James, Laura E Forrest. Eur J Hum Genet 2019
Erin Tutty, Lara Petelin, Joanne McKinley, Mary-Anne Young, Bettina Meiser, Victoria M Rasmussen, Rowan Forbes Shepherd, Paul A James, Laura E Forrest. Eur J Hum Genet 2019
23
Barriers and motivators for referral of patients with suspected lynch syndrome to cancer genetic services: a qualitative study.
Yen Y Tan, Lisa J Fitzgerald. J Pers Med 2014
Yen Y Tan, Lisa J Fitzgerald. J Pers Med 2014
25
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.
Andrea C Tricco, Erin Lillie, Wasifa Zarin, Kelly K O'Brien, Heather Colquhoun, Danielle Levac, David Moher, Micah D J Peters, Tanya Horsley, Laura Weeks,[...]. Ann Intern Med 2018
Andrea C Tricco, Erin Lillie, Wasifa Zarin, Kelly K O'Brien, Heather Colquhoun, Danielle Levac, David Moher, Micah D J Peters, Tanya Horsley, Laura Weeks,[...]. Ann Intern Med 2018
13
The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients.
M Gleeson, M Kentwell, B Meiser, J Do, S Nevin, N Taylor, K Barlow-Stewart, J Kirk, P James, C L Scott,[...]. Gynecol Oncol 2020
M Gleeson, M Kentwell, B Meiser, J Do, S Nevin, N Taylor, K Barlow-Stewart, J Kirk, P James, C L Scott,[...]. Gynecol Oncol 2020
33
Adopting clinical genomics: a systematic review of genomic literacy among physicians in cancer care.
Vu T Dung Ha, Julie Frizzo-Barker, Peter Chow-White. BMC Med Genomics 2018
Vu T Dung Ha, Julie Frizzo-Barker, Peter Chow-White. BMC Med Genomics 2018
14
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
9
The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.
D Gareth Evans, Julian Barwell, Diana M Eccles, Amanda Collins, Louise Izatt, Chris Jacobs, Alan Donaldson, Angela F Brady, Andrew Cuthbert, Rachel Harrison,[...]. Breast Cancer Res 2014
D Gareth Evans, Julian Barwell, Diana M Eccles, Amanda Collins, Louise Izatt, Chris Jacobs, Alan Donaldson, Angela F Brady, Andrew Cuthbert, Rachel Harrison,[...]. Breast Cancer Res 2014
9
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
9
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
Ranjit Manchanda, Rosa Legood, Matthew Burnell, Alistair McGuire, Maria Raikou, Kelly Loggenberg, Jane Wardle, Saskia Sanderson, Sue Gessler, Lucy Side,[...]. J Natl Cancer Inst 2014
Ranjit Manchanda, Rosa Legood, Matthew Burnell, Alistair McGuire, Maria Raikou, Kelly Loggenberg, Jane Wardle, Saskia Sanderson, Sue Gessler, Lucy Side,[...]. J Natl Cancer Inst 2014
9
Clinical validity assessment of genes frequently tested on hereditary breast and ovarian cancer susceptibility sequencing panels.
Kristy Lee, Bryce A Seifert, Hermela Shimelis, Rajarshi Ghosh, Stephanie B Crowley, Natalie J Carter, Kurston Doonanco, A Katherine Foreman, Deborah I Ritter, Sharisse Jimenez,[...]. Genet Med 2019
Kristy Lee, Bryce A Seifert, Hermela Shimelis, Rajarshi Ghosh, Stephanie B Crowley, Natalie J Carter, Kurston Doonanco, A Katherine Foreman, Deborah I Ritter, Sharisse Jimenez,[...]. Genet Med 2019
9
Lifetime cancer risks in individuals with germline PTEN mutations.
Min-Han Tan, Jessica L Mester, Joanne Ngeow, Lisa A Rybicki, Mohammed S Orloff, Charis Eng. Clin Cancer Res 2012
Min-Han Tan, Jessica L Mester, Joanne Ngeow, Lisa A Rybicki, Mohammed S Orloff, Charis Eng. Clin Cancer Res 2012
9
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
9
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
Pardeep Kaurah, Andrée MacMillan, Niki Boyd, Janine Senz, Alessandro De Luca, Nicki Chun, Gianpaolo Suriano, Sonya Zaor, Lori Van Manen, Cathy Gilpin,[...]. JAMA 2007
Pardeep Kaurah, Andrée MacMillan, Niki Boyd, Janine Senz, Alessandro De Luca, Nicki Chun, Gianpaolo Suriano, Sonya Zaor, Lori Van Manen, Cathy Gilpin,[...]. JAMA 2007
9
Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
Phuong L Mai, Ana F Best, June A Peters, Rosamma M DeCastro, Payal P Khincha, Jennifer T Loud, Renée C Bremer, Philip S Rosenberg, Sharon A Savage. Cancer 2016
Phuong L Mai, Ana F Best, June A Peters, Rosamma M DeCastro, Payal P Khincha, Jennifer T Loud, Renée C Bremer, Philip S Rosenberg, Sharon A Savage. Cancer 2016
9
Population Frequency of Germline BRCA1/2 Mutations.
Kara N Maxwell, Susan M Domchek, Katherine L Nathanson, Mark E Robson. J Clin Oncol 2016
Kara N Maxwell, Susan M Domchek, Katherine L Nathanson, Mark E Robson. J Clin Oncol 2016
9
Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.
Jennifer Gill, Adam J Obley, Vinay Prasad. JAMA 2018
Jennifer Gill, Adam J Obley, Vinay Prasad. JAMA 2018
9
Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
9
Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
Peter D Beitsch, Pat W Whitworth, Kevin Hughes, Rakesh Patel, Barry Rosen, Gia Compagnoni, Paul Baron, Rache Simmons, Linda Ann Smith, Ian Grady,[...]. J Clin Oncol 2019
Peter D Beitsch, Pat W Whitworth, Kevin Hughes, Rakesh Patel, Barry Rosen, Gia Compagnoni, Paul Baron, Rache Simmons, Linda Ann Smith, Ian Grady,[...]. J Clin Oncol 2019
9
Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care.
Ella R Thompson, Simone M Rowley, Na Li, Simone McInerny, Lisa Devereux, Michelle W Wong-Brown, Alison H Trainer, Gillian Mitchell, Rodney J Scott, Paul A James,[...]. J Clin Oncol 2016
Ella R Thompson, Simone M Rowley, Na Li, Simone McInerny, Lisa Devereux, Michelle W Wong-Brown, Alison H Trainer, Gillian Mitchell, Rodney J Scott, Paul A James,[...]. J Clin Oncol 2016
9
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.
Ranjit Manchanda, Shreeya Patel, Vladimir S Gordeev, Antonis C Antoniou, Shantel Smith, Andrew Lee, John L Hopper, Robert J MacInnis, Clare Turnbull, Susan J Ramus,[...]. J Natl Cancer Inst 2018
Ranjit Manchanda, Shreeya Patel, Vladimir S Gordeev, Antonis C Antoniou, Shantel Smith, Andrew Lee, John L Hopper, Robert J MacInnis, Clare Turnbull, Susan J Ramus,[...]. J Natl Cancer Inst 2018
9
Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trial.
Marijke R Wevers, Margreet G E M Ausems, Senno Verhoef, Eveline M A Bleiker, Daniela E E Hahn, Titia Brouwer, Frans B L Hogervorst, Rob B van der Luijt, Thijs van Dalen, Evert B Theunissen,[...]. Genet Med 2016
Marijke R Wevers, Margreet G E M Ausems, Senno Verhoef, Eveline M A Bleiker, Daniela E E Hahn, Titia Brouwer, Frans B L Hogervorst, Rob B van der Luijt, Thijs van Dalen, Evert B Theunissen,[...]. Genet Med 2016
9
Validation of a decision regret scale.
Jamie C Brehaut, Annette M O'Connor, Timothy J Wood, Thomas F Hack, Laura Siminoff, Elisa Gordon, Deb Feldman-Stewart. Med Decis Making 2003
Jamie C Brehaut, Annette M O'Connor, Timothy J Wood, Thomas F Hack, Laura Siminoff, Elisa Gordon, Deb Feldman-Stewart. Med Decis Making 2003
9
Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer.
Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. N Engl J Med 2012
Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. N Engl J Med 2012
9
Physician interpretation of variants of uncertain significance.
Sarah K Macklin, Jessica L Jackson, Paldeep S Atwal, Stephanie L Hines. Fam Cancer 2019
Sarah K Macklin, Jessica L Jackson, Paldeep S Atwal, Stephanie L Hines. Fam Cancer 2019
9
Precision medicine in pediatric oncology: Lessons learned and next steps.
Rajen J Mody, John R Prensner, Jessica Everett, D Williams Parsons, Arul M Chinnaiyan. Pediatr Blood Cancer 2017
Rajen J Mody, John R Prensner, Jessica Everett, D Williams Parsons, Arul M Chinnaiyan. Pediatr Blood Cancer 2017
9
Communication challenges for nongeneticist physicians relaying clinical genomic results.
Nonie S Arora, J Kelly Davis, Christine Kirby, Amy L McGuire, Robert C Green, J S Blumenthal-Barby, Peter A Ubel. Per Med 2016
Nonie S Arora, J Kelly Davis, Christine Kirby, Amy L McGuire, Robert C Green, J S Blumenthal-Barby, Peter A Ubel. Per Med 2016
9
Healthcare professionals' attitudes toward cancer precision medicine: A systematic review.
J Vetsch, C E Wakefield, P Techakesari, M Warby, D S Ziegler, T A O'Brien, C Drinkwater, N Neeman, K Tucker. Semin Oncol 2019
J Vetsch, C E Wakefield, P Techakesari, M Warby, D S Ziegler, T A O'Brien, C Drinkwater, N Neeman, K Tucker. Semin Oncol 2019
28
Precision medicine in pediatric oncology.
Suzanne J Forrest, Birgit Geoerger, Katherine A Janeway. Curr Opin Pediatr 2018
Suzanne J Forrest, Birgit Geoerger, Katherine A Janeway. Curr Opin Pediatr 2018
9
Barriers to and motivations for physician referral of patients to cancer genetics clinics.
Carrie F Prochniak, Lisa J Martin, Erin M Miller, Sara C Knapke. J Genet Couns 2012
Carrie F Prochniak, Lisa J Martin, Erin M Miller, Sara C Knapke. J Genet Couns 2012
9
Differences in BRCA counseling and testing practices based on ordering provider type.
Deborah Cragun, Lucia Camperlengo, Emily Robinson, Meghan Caldwell, Jongphil Kim, Catherine Phelan, Alvaro N Monteiro, Susan T Vadaparampil, Thomas A Sellers, Tuya Pal. Genet Med 2015
Deborah Cragun, Lucia Camperlengo, Emily Robinson, Meghan Caldwell, Jongphil Kim, Catherine Phelan, Alvaro N Monteiro, Susan T Vadaparampil, Thomas A Sellers, Tuya Pal. Genet Med 2015
9
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.